Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-16-091600
Filing Date
2016-03-30
Accepted
2016-03-30 17:16:33
Documents
59
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v435519_10k.htm 10-K 696764
2 EXHIBIT 21 v435519_ex21.htm EX-21 2330
3 EXHIBIT 23.1 v435519_ex23-1.htm EX-23.1 2299
4 EXHIBIT 31.1 v435519_ex31-1.htm EX-31.1 9156
5 EXHIBIT 31.2 v435519_ex31-2.htm EX-31.2 9354
6 EXHIBIT 32 v435519_ex32.htm EX-32 5090
  Complete submission text file 0001144204-16-091600.txt   4657579

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT accp-20151231.xml EX-101.INS 724079
8 XBRL TAXONOMY EXTENSION SCHEMA accp-20151231.xsd EX-101.SCH 47312
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE accp-20151231_cal.xml EX-101.CAL 69460
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE accp-20151231_def.xml EX-101.DEF 222916
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE accp-20151231_lab.xml EX-101.LAB 727728
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE accp-20151231_pre.xml EX-101.PRE 386826
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 161540734
SIC: 2834 Pharmaceutical Preparations